Physician

Abhijit Prakash Limaye, MD

According to 2025 Medicare claims, Abhijit Limaye, MD (NPI: 1205972239) practices infectious disease in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1760552343; TIN: 943281662) and primary practice location at 94143-2204.

Limaye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 39 traditional Medicare patients, billed 68 HCPCS/CPT codes, and received $7,598 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 52 prescription claims totaling $5,925 in drug costs, led by Ceftazidime (Ceftazidime). Open Payments data shows 15 records totaling $283,754. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $17,603 and ending at $7,598. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $24,192 to $5,925. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$15K$29K2015 Medicare payment: $17,603 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $26,835 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $17,793 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $21,132 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $27,092 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $29,008 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $23,114 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $20,951 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $14,109 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,598 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201589192$17,603
2016140293$26,835
2017106182$17,793
2018106212$21,132
2019124254$27,092
2020111270$29,008
202187219$23,114
202285185$20,951
202371123$14,109
20243968$7,598

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$29K2015 Drug cost: $24,192 (USD; Tot_Drug_Cst)2016 Drug cost: $12,136 (USD; Tot_Drug_Cst)2017 Drug cost: $16,333 (USD; Tot_Drug_Cst)2018 Drug cost: $19,635 (USD; Tot_Drug_Cst)2019 Drug cost: $29,320 (USD; Tot_Drug_Cst)2020 Drug cost: $15,088 (USD; Tot_Drug_Cst)2021 Drug cost: $11,589 (USD; Tot_Drug_Cst)2022 Drug cost: $11,245 (USD; Tot_Drug_Cst)2023 Drug cost: $8,661 (USD; Tot_Drug_Cst)2024 Drug cost: $5,925 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151957$24,192
20162051$12,136
20171974$16,333
20182377$19,635
20192771$29,320
202021101$15,088
20211666$11,589
20221258$11,245
20231457$8,661
2024N/R52$5,925

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1515$153
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1520$105

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CeftazidimeCeftazidime1389$2,833
Vancomycin HclVancomycin Hcl14375$1,884

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$12,682GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.8$271,073University Of Washington Med Ctr
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abhijit Prakash Limaye, MD?

Tedicare shows public-source Medicare data for Abhijit Prakash Limaye, MD (NPI 1205972239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhijit Prakash Limaye, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhijit Prakash Limaye, MD?

Abhijit Prakash Limaye, MD is linked to REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1760552343) in the available physician profile data.

Does Abhijit Prakash Limaye, MD have Open Payments data?

Abhijit Prakash Limaye, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.